All Christus Health Sponsors for H1B Applications - 2023

Explore H1B salary data for top companies like Christus-health across different cities for various job titles and discover the average salaries.

Company name
Job Title
City Name
Average Salary
Christus Health Information Services Developer I Irving $ 98,010 / Year
Christus Health Information Services Developer Ii Irving $ 112,008 / Year
Christus Health Information Services Developer Ii Irving $ 112,008 / Year
Christus Health Cls Medical Technologist Irving $ 56,160 / Year
Christus Health Clinical Laboratory Scientist Irving $ 46,280 / Year
Christus Health Information Services Developer Ii Irving $ 112,008 / Year
Christus Health Web Design Analyst I Irving $ 67,995 / Year
Christus Health System Administrator Lead Irving $ 63 / Hour
Christus Health Clsmedical Technologist Irving $ 49,670 / Year
Christus Health Clsmedical Technologist Irving $ 49,670 / Year
Christus Health Information Services Developer Ii Irving $ 112,008 / Year
Christus Health Information Services Developer Irving $ 112,008 / Year
Christus Health Information Services Developer Ii Irving $ 112,008 / Year
Christus Health Financial Analyst Lead Irving $ 90,002 / Year
Christus Health Financial Analyst Lead Irving $ 90,002 / Year
Christus Health Data Scientist Ii Irving $ 110,011 / Year
Christus Health Financial Analyst Lead Irving $ 90,002 / Year
Christus Health Clinical Laboratory Scientist Medical Technologist Irving $ 68,224 / Year
Christus Health Clinical Laboratory Scientist Medical Technologist Irving $ 51,480 / Year
Christus Health Manager Pastoral Care Irving $ 76,232 / Year

Last 5 Years H-1B Salary Data

h1bInfo.org is an independent website that displays public disclosure data in a user-friendly format. We have analyzed 10 years of H1B data from USCIS and the US Department of Labor, covering more than 6 million records from FY 2014 to FY 2023. However, for the latest and most accurate data, it's best to check the official sources directly. All content on H1BInfo is copyrighted and all rights are reserved from 2022 to 2023.